SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Galena Biopharm...
April 09 2014 - 5:14PM
Business Wire
Brower Piven, A Professional Corporation announces that a class
action lawsuit has been commenced in the United States District
Court for the District of Oregon on behalf of purchasers of Galena
Biopharma, Inc. (“Galena” or the “Company”) (Nasdaq: GALE) common
stock during the period between November 6, 2013 and February 14,
2014, inclusive (the “Class Period”).
If you have suffered a net loss from investment in Galena common
stock purchased on or after November 6, 2013 and held through the
revelation of negative information during and/or at the end of the
Class Period, and would like to learn more about this lawsuit and
your ability to participate as a lead plaintiff, without cost or
financial obligation, click here:
http://www.browerpiven.com/securitiesfraudcases.html.
You may also request more information by contacting Brower Piven
either by email at hoffman@browerpiven.com or by telephone at (410)
415-6616. Attorneys at Brower Piven together have more than a
century of experience litigating securities and other class action
cases.
No class has yet been certified in the above action. Members of
the Class will be represented by the lead plaintiff and counsel
chosen by the lead plaintiff. If you wish to choose counsel to
represent you and the Class, you must apply to be appointed lead
plaintiff no later than May 5, 2014 and be selected by the Court.
The lead plaintiff will direct the litigation and participate in
important decisions including whether to accept a settlement and
how much of a settlement to accept for the Class in the action. The
lead plaintiff will be selected from among applicants claiming the
largest loss from investment in Company units during the Class
Period.
The complaint accuses the defendants of violations of the
Securities Exchange Act of 1934 by virtue of the defendants’
failure to disclose during the Class Period that to boost its stock
price, the Company engaged in a misleading brand awareness
campaign, including hiring investor relations firm The DreamTeam
Group (“DreamTeam”) to publish articles under aliases promoting the
Company’s stock without disclosing who paid for them. According to
the complaint, following the February 12, 2014, publication of an
article by Adam Feuerstein on TheStreet.com disclosing allegations
of Galena’s misleading brand awareness campaign and the Company’s
February 14, 2014 acknowledgment that the Company had indeed
engaged DreamTeam, the value of Galena shares declined
significantly.
If you choose to retain counsel, you may retain Brower Piven
without financial obligation or cost to you, or you may retain
other counsel of your choice. You need take no action at this time
to be a member of the class.
Brower Piven, A Professional Corporation1925 Old Valley
RoadStevenson, Maryland, 21153Charles J. Piven,
410-415-6616hoffman@browerpiven.com
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Apr 2023 to Apr 2024